Search

Search results

316 results found

Hematology-oncology provider perspectives regarding lymphoma treatment and cardioprotective strategies in patients with lymphoma at high risk for heart failure.

Anderson, Emily, Yun Choi, Rachel J Buchsbaum, Andreas Klein, Bonnie Ky, Daniel Landsburg, Urshila Durani, et al. 2025. “Hematology-Oncology Provider Perspectives Regarding Lymphoma Treatment and Cardioprotective Strategies in Patients With Lymphoma at High Risk for Heart Failure.”. Leukemia & Lymphoma, 1-10.

Dhruv Kazi, MD, MSc, MS

Dhruv Kazi, MD, MSc, MS serves as the Associate Director of and Section Head of Health Economics at the Smith Center. At BIDMC, he is the Director of the Cardiac Critical Care Unit. He is a general cardiologist and health economist who uses real-world data and mathematical modeling to examine the...

Fellow Spotlights

Maxime Lebaz-Dubosq, MD - September 2025 Azariah Boyd, MS - July 2025 Christopher Koo, MRCP, MCI - July 2025 Daniel Johnson, BA - June 2025 Frank Medina, BA - April 2025

Robert Yeh, MD, MSc, MBA

Robert W. Yeh, MD, MSc, MBA is the Director of the Richard A. and Susan F. Smith Center for Outcomes Research and Section Chief of Interventional Cardiology at Beth Israel Deaconess Medical Center, and the Katz Silver Family Endowed Chair and Professor of Medicine in the Field of Outcomes Research...

Outcomes of Endovascular Revascularization for Chronic Limb-Threatening Ischemia in Medicare Advantage and Medicare Fee-For-Service Beneficiaries.

Dangas, Katerina, Joseph M Kim, Siling Li, Yang Song, Andrew S Oseran, Robert W Yeh, Rishi K Wadhera, and Eric A Secemsky. 2025. “Outcomes of Endovascular Revascularization for Chronic Limb-Threatening Ischemia in Medicare Advantage and Medicare Fee-For-Service Beneficiaries.”. Circulation. Cardiovascular Quality and Outcomes 18 (10): e012099.